Anti-HBe may play a role in the progression of the disease of hepatitis B

Genotype D is found to be the only detected type in different clinical forms of HBV infections, including cirrhosis, among residents of southwestern Iran. A significant association between the presence of anti-HBe antibody and increasing ALT levels among either HBeAg-negative or HBeAg-positive individuals was also determined.

This study, performed by a team led by Dr. A Behzad-Behbahani, is described in a research article to be published on March 14, 2008, in the World Journal of Gastroenterology.

The heterogeneity in the global distribution of HBV genotypes may account for differences in the clinical outcomes of HBV infections and in the responses to antiviral treatment. The clinical and serological statuses of the patients infected with a specific genotype of HBV in this geographic region (southwestern Iran) need to be further investigated.

Serum samples were collected from HBsAg-positive subjects attending the Gastroenterology and Hepatology Clinic at the Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, in southwestern Iran. The definition and diagnostic criteria for clinical terms were adopted from the American Association for the Study of Liver Disease (AASLD) practice guidelines. All sera were then investigated to determine HBV DNA and serological markers. For all the positive quantitative PCR samples, biochemical and histopathological assays and genotyping were also performed. Quantitative real-time PCR assays were carried out using SYBER-Green signal detection. Abdominal ultrasounds were also performed to determine if there were features of cirrhosis. Liver biopsies were performed based on clinical indications.

Genotype D was the only type detected in different clinical forms of acute and chronic infections. There was an increased prevalence of HBeAg-negative status among HBV-infected patients with chronic hepatitis. Cirrhosis was diagnosed among patients with chronic hepatitis. A significant association between the presence of anti-HBe antibody and the increase in ALT levels among either HBeAg-negative or HBeAg-positive individuals was demonstrated. No significant differences were observed between the clinical outcomes of HBeAg-positive and ¨Cnegative patients.

In the view of the authors, this report shows the prevalence of this specific genotype of HBV and its clinical relevance in a part of the Middle East. This isolated genotype is associated with active disease, cirrhosis and hepatocellular carcinoma. A significant number of patients infected with genotype D were HBeAg-negative. Another interesting finding was that a large number of patients with positive anti-HBe had elevated ALT levels.

Using a prospective cohort study in a group of patients infected with HBV genotype D would be helpful to assess the clinical outcomes of different management strategies for the patients. An in vitro study needs to be established in order to clarify the molecular biology of different HBV genotypes.

Further research should explain the mechanism of pathogenesis of different HBV genotypes in specific geographical regions.

Reference: Mojiri A, Behzad-Behbahani A, Saberifirozi M, Ardabili M, Beheshti M, Rahsaz M, Banihashemi M, Azarpira N, Geramizadeh B, Khadang B, Moaddeb A, Ghaedi M, Heidari T, Torab A, Salah AR, Amirzadeh S, Jowkar Z, Mehrabani D, Amini-Bavil-Olyaee S, Dehyadegari MA. Hepatitis B virus genotypes in southwest Iran: Molecular, serological and clinical outcomes. World J Gastroenterol 2008; 14(10): 1510-1513
http://www.wjgnet.com/1007-9327/14/1510.asp

Correspondence to: Abbas Behzad-Behbahani, School of Paramedical Sciences, Shiraz University of Medical Sciences, Meshkinfam St. 7143914693, Shiraz, Iran. behbahani_2000@yahoo.com
Telephone: +98-711-2295023 Fax: +98-711-2289113

World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection for providing a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th day of every month. The WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the name of China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.

The WJG Press mainly publishes World Journal of Gastroenterology.